Immuneering Corporation
Immuneering Corporation scores highest on Anchor (62) and lowest on Earnings (32). Its PosiPenta is 44.51 out of 100, around the middle of similar companies.
On the Penta Grid this week, Immuneering Corporation is Grid #395 of 837 in the Healthcare sector in United States, and Grid #2,465 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Immuneering Corporation | 44.51 | 37 | 32 | 33 | 58 | 62 |
| Vanda Pharmaceuticals Inc. | 41.72 | 38 | 48 | 24 | 43 | 55 |
| Monogram Technologies Inc. | 50.30 | 2 | 45 | 94 | 38 | 72 |
| Lineage Cell Therapeutics, Inc. | 41.05 | 16 | 56 | 39 | 52 | 41 |
| Standard BioTools Inc. | 48.86 | 46 | 74 | 20 | 64 | 39 |
| Fate Therapeutics, Inc. | 39.22 | 34 | 38 | 59 | 37 | 29 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.86 |
| P/B ratio | 1.22 |
EEarnings
| Trailing EPS | ₹-88.08 |
| Forward EPS | ₹-118.93 |
NNitro
| Price | 340.03 |
| 52-week high | 803.18 |
| 52-week low | 320.14 |
| Fall from 52-week high | 57.7% |
TTorque
| Return on equity (ROE) | -52.15% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.46 |
| Market cap | ₹2,199 Cr |
| Insider holding | 13.83% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Immuneering Corporation's PosiPenta score?
Immuneering Corporation's PosiPenta is 44.51 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Immuneering Corporation stand on the Penta Grid?
On the Penta Grid this week, Immuneering Corporation is Grid #395 of 837 in the Healthcare sector in United States, and Grid #2,465 of 4,000 in United States.
Which PosiPenta pillar is strongest for Immuneering Corporation?
Anchor (stability and dividends), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Immuneering Corporation?
Earnings (growth), with a score of 32 out of 100: weaker than most similar companies.
Has Immuneering Corporation's PosiPenta changed since last week?
Yes, it rose 5.39 points, from 39.12 to 44.51.
PositoAI is for research and education only and is not investment advice.